Biomanufacturing has emerged as a strategic emerging industry worldwide, offering sustainable alternatives to conventional chemical manufacturing. To support this development, diverse production chassis have been developed, including microorganisms, mammalian cell culture systems, and plant-based platforms. Among these, plants represent a promising chassis for the biosynthesis of high-value products, as they directly fix CO₂ through photosynthesis and possess sophisticated metabolic networks that facilitate the production of structurally complex molecules. Recent advances in synthetic biology have increased the programmability of plant systems and enabled their development as engineered production chassis for the production of high-value products. This review integrates recent advances in natural and synthetic genetic elements including promoters, terminators, and transcription factors (TFs) that facilitate chassis development are summarized. Recent advances in the elucidation, reconstruction, and optimization of biosynthetic pathways for representative classes of valuable compounds, including alkaloids, terpenoids, and phenylpropanoids, are then highlighted, with particular emphasis on pathway engineering strategies that enhance productivity. Finally, we outline the key challenges and future perspectives for the large-scale industrial applications of plant chassis. This review provides a comprehensive and timely perspective on plant-based biomanufacturing, offering conceptual guidance and practical insights for advancing plant chassis from laboratory research to sustainable industrial applications.
A host-centric perspective is provided by comparing conventional and emerging microbial cell factories, highlighting their physiological strengths, product spectrum, industrial applicability, and strategic considerations for sustainable and application-specific terpenoid biomanufacturing.
Vibha Shukla, V. Shukla, Shweta Rawat et al.· Frontiers in Bioengineering...· 0 citations
This Review systematically examines synthetic biology-driven strategies for improving sclareol production, with particular emphasis on microbial chassis engineering, metabolic pathway optimization, and enzyme engineering.
Yi-Wen Yu, Long-Qing Wang, Yan Zhang et al.· ACS Omega· 0 citations
Polyketides are among the most structurally diverse and therapeutically important classes of natural products, serving as antibiotics, anticancer agents, agrochemicals, and industrial pigments. Their structural complexity and limited natural availability have driven the development of microbial biosynthetic platforms a...
Polyhydroxyalkanoates (PHAs) are microbially synthesized biopolyesters that have emerged as sustainable alternatives to conventional plastics due to their biodegradability, biocompatibility, and versatile material properties. Among various microbial producers, Streptomyces species have gained attention as promising yet...
The long-term and extensive use of conventional chemical pesticides has led to a series of problems, including pesticide resistance in plant pathogens and insect pests, environmental pollution, and risks to the safety of agricultural products. These challenges have created an urgent need for green, efficient, and susta...
Li Fan, Kai-Feng Wang, Lu Lin et al.· Biotechnology Advances· 0 citations
This review provides the current state of PHAs production from wild yeast strains and the various approaches that have been used to improve yield, and discusses the performance, challenges, and limitations of various synthetic biology and metabolic engineering strategies in yeast strains for PHAs production.
K. Mohanrasu, R. Selvakumar, I. Grainge et al.· International Journal of Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.